These dermatological disorders share the features of being caused by hyperactivity of androgen within the pilosebaceous follicle, and although not life threatening are the source of a considerable psychological and emotional burden for patients. Foreword.
作者信息
Maloney J Michael
机构信息
Cherry Creek Dermatology, Denver, Colorado, USA.
出版信息
Am J Clin Dermatol. 2011 Sep 6;12 Suppl 1(Suppl 1):1-2. doi: 10.2165/1159613-S0-000000000-00000.
Abstract
摘要
相似文献
1
These dermatological disorders share the features of being caused by hyperactivity of androgen within the pilosebaceous follicle, and although not life threatening are the source of a considerable psychological and emotional burden for patients. Foreword.这些皮肤病的共同特征是由毛囊内雄激素活性过高引起，虽然不危及生命，但给患者带来了相当大的心理和情感负担。前言。
Am J Clin Dermatol. 2011 Sep 6;12 Suppl 1(Suppl 1):1-2. doi: 10.2165/1159613-S0-000000000-00000.
2
Ethinylestradiol/Chlormadinone acetate: dermatological benefits.炔雌醇/氯地孕酮：皮肤科获益。
Am J Clin Dermatol. 2011 Sep 6;12 Suppl 1(Suppl 1):3-11. doi: 10.2165/1153874-S0-000000000-00000.
3
Ethinylestradiol/Chlormadinone acetate for use in dermatological disorders.屈螺酮炔雌醇/醋酸氯地孕酮用于皮肤科疾病。
Am J Clin Dermatol. 2011 Sep 6;12 Suppl 1(Suppl 1):13-9. doi: 10.2165/1153875-S0-000000000-00000.
4
Ethinylestradiol/chlormadinone acetate.炔雌醇/醋酸氯地孕酮
Drugs. 2004;64(7):751-60; discussion 761-2. doi: 10.2165/00003495-200464070-00005.
5
Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome.口服含有炔雌醇和氯地孕酮的复方避孕药治疗非肥胖型多囊卵巢综合征妇女的内分泌、代谢和临床特征。
Contraception. 2010 Aug;82(2):131-8. doi: 10.1016/j.contraception.2010.01.022. Epub 2010 Mar 1.
6
Evaluation of efficacy, safety and effects on symptoms of androgenization of a generic oral contraceptive containing chlormadinone acetate 2 mg/ethinylestradiol 0.03 mg.评估含有 2 毫克氯地孕酮醋酸酯/0.03 毫克乙炔雌二醇的通用口服避孕药的疗效、安全性和雄激素化症状的影响。
Contraception. 2012 Oct;86(4):359-65. doi: 10.1016/j.contraception.2012.02.004. Epub 2012 Mar 23.
7
The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome.2 毫克氯地孕酮/30 微克炔雌醇单独或与螺内酯联合应用对多囊卵巢综合征妇女心血管风险标志物的影响。
Contraception. 2012 Sep;86(3):268-75. doi: 10.1016/j.contraception.2011.12.011. Epub 2012 Mar 28.
8
[Radioimmunological study of the effect of hormonal contraceptives upon the progesterone level of saliva (author's transl)].激素避孕药对唾液孕酮水平影响的放射免疫研究（作者译）
Zahn Mund Kieferheilkd Zentralbl. 1980;68(7):713-8.
9
Ethinylestradiol-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: evaluation of the metabolic impact.炔雌醇环丙孕酮醋酸酯联合治疗多囊卵巢综合征正常体重女性多毛症和激素改变：评估代谢影响。
Reprod Sci. 2010 Aug;17(8):767-75. doi: 10.1177/1933719110371515.
10
Extended cycles with the combined oral contraceptive chlormadinone acetate 2 mg/ethinylestradiol 0.03 mg: pooled analysis of data from three large-scale, non-interventional, observational studies.含屈螺酮 2mg/炔雌醇 0.03mg 的复方口服避孕药延长周期：来自三项大规模、非干预、观察性研究数据的汇总分析。
Clin Drug Investig. 2011;31(4):269-77. doi: 10.2165/11586720-000000000-00000.
Zotero 插件